MAPT and Alzheimer disease: Indeed, detection of Aβ and tau deposition in cerebrospinal fluid (CSF) or positron emission tomography (PET) imaging presents now an antemortem AD neuropathology diagnosis (Bridel et al., 2019; Lowe et al., 2019).